Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 18;7(17):14412-14429.
doi: 10.1021/acsomega.2c00588. eCollection 2022 May 3.

The 18-kDa Translocator Protein PET Tracers as a Diagnostic Marker for Neuroinflammation: Development and Current Standing

Priya Singh  1 , Anupriya Adhikari  1 , Deepika Singh  1 , Chandraprakash Gond  1 , Anjani Kumar Tiwari  1
Affiliations
Review

The 18-kDa Translocator Protein PET Tracers as a Diagnostic Marker for Neuroinflammation: Development and Current Standing

Priya Singh et al. ACS Omega. .

Abstract

Translocator protein (TSPO, 18 kDa) is an evolutionary, well-preserved, and tryptophan-rich 169-amino-acid protein which localizes on the contact sites between the outer and inner mitochondrial membranes of steroid-synthesizing cells. This mitochondrial protein is implicated in an extensive range of cellular activities, including steroid synthesis, cholesterol transport, apoptosis, mitochondrial respiration, and cell proliferation. The upregulation of TSPO is well documented in diverse disease conditions including neuroinflammation, cancer, brain injury, and inflammation in peripheral organs. On the basis of these outcomes, TSPO has been assumed to be a fascinating subcellular target for early stage imaging of the diseased state and for therapeutic purposes. The main outline of this Review is to give an update on dealing with the advances made in TSPO PET tracers for neuroinflammation, synchronously emphasizing the approaches applied for the design and advancement of new tracers with reference to their structure-activity relationship (SAR).

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Schematic representation of various TSPO functions.
Figure 2
Figure 2
Schematic diagram demonstrating cholesterol metabolism in steroidogenic cells.
Figure 3
Figure 3
Sequential categorization of PET Tracers.
Figure 4
Figure 4
First generation TSPO tracers.
Figure 5
Figure 5
Second generation TSPO tracers.
Figure 5
Figure 5
Second generation TSPO tracers.
Figure 6
Figure 6
Structural view of new generation PET tracers for TSPO.
See this image and copyright information in PMC

References

    1. Papadopoulos V.; Baraldi M.; Guilarte T. R.; Knudsen T. B.; Lacapère J. J.; Lindemann P.; Norenberg M. D.; Nutt D.; Weizman A.; Zhang M. R.; Gavish M. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 2006, 27, 402–409. 10.1016/j.tips.2006.06.005. - DOI - PubMed
    1. Scarf A. M.; Kassiou M. The translocator protein. J. Nucl. Med. 2011, 52, 677–680. 10.2967/jnumed.110.086629. - DOI - PubMed
    1. Werry E. L.; Bright F. M.; Piguet O.; Ittner L. M.; Halliday G. M.; Hodges J. R.; Kiernan M. C.; Loy C. T.; Kril J. J.; Kassiou M. Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders. Int. J. Mol. Sci. 2019, 20, 3161. 10.3390/ijms20133161. - DOI - PMC - PubMed
    1. Rupprecht R.; Papadopoulos V.; Rammes G.; Baghai T. C.; Fan J.; Akula N.; Groyer G.; Adams D.; Schumacher M. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discovery 2010, 9, 971–988. 10.1038/nrd3295. - DOI - PubMed
    1. Sinha D.; Shukla G.; Tiwari A. K.; Chaturvedi S.; Chuttani K.; Chandra H.; Mishra A. K. 99mTc-DTPA-amino acids conjugate as specific SPECT pharmaceuticals for tumor imaging. Chem. Biol. Drug Des. 2009, 74 (2), 159–164. 10.1111/j.1747-0285.2009.00839.x. - DOI - PubMed